Artificial Intelligence and Technology Collaboratory (P30 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is inviting applications for the Artificial Intelligence and Technology Collaboratory (P30 Clinical Trial Optional) grant, aimed at promoting the development and implementation of artificial intelligence (AI) and technology in aging and Alzheimer's Disease (AD) research. This funding opportunity seeks to establish national resources and support research projects that address ethical challenges and algorithmic fairness in AI, with a focus on aging and AD-related dementias (ADRD). The NIH anticipates awarding up to four grants, each valued at $4.9 million over a five-year period, with applications due by October 15, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.